Is bisoprolol longer acting than propranolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bisoprolol is Longer Acting Than Propranolol

Bisoprolol is definitively the longer-acting beta-blocker, with a plasma elimination half-life of 9-12 hours allowing once-daily dosing, compared to propranolol's shorter half-life of 3-6 hours (8-11 hours for extended-release formulations) requiring multiple daily doses.

Pharmacokinetic Comparison

Bisoprolol

  • Half-life: 9-12 hours 1
  • Dosing frequency: Once daily 2, 3, 1
  • Time to peak concentration: 2-4 hours 1
  • Steady state: Achieved within 5 days of once-daily dosing 1
  • Bioavailability: ~80% with minimal first-pass metabolism (20%) 1
  • Elimination: Balanced—50% renal (unchanged), 50% hepatic metabolism 1, 4

Propranolol

  • Half-life:
    • Immediate-release: 3-6 hours (requires 2-4 times daily dosing) 5
    • Extended-release: 8-11 hours 6
  • Dosing frequency: 2-4 times daily for immediate-release; once daily for extended-release 2, 3, 7
  • Bioavailability: Highly variable due to extensive first-pass metabolism 6, 4
  • Elimination: Primarily hepatic metabolism 4

Clinical Implications

The longer duration of action with bisoprolol provides several advantages:

Consistent 24-hour coverage: Bisoprolol maintains therapeutic beta-blockade throughout a full 24-hour period with once-daily dosing 1, 8. Research comparing bisoprolol 10 mg once daily to propranolol 80 mg twice daily demonstrated that bisoprolol's antihypertensive and negative chronotropic effects remained effective 24 hours after administration 9.

More stable plasma concentrations: Bisoprolol shows less interpatient variability in steady-state plasma levels due to its balanced renal-hepatic elimination 4. Propranolol, being highly lipophilic with extensive hepatic metabolism, exhibits substantial interpatient variability and is subject to drug interactions affecting hepatic enzymes 4.

Improved compliance potential: The once-daily dosing of bisoprolol versus the 2-4 times daily requirement for immediate-release propranolol enhances medication adherence 8, 6.

Guideline-Recommended Dosing

Major cardiovascular guidelines consistently recommend:

  • Bisoprolol: 2.5-10 mg once daily 2, 3, 7
  • Propranolol IR: 80-160 mg divided 2-4 times daily 2, 3, 7
  • Propranolol LA: 80-160 mg once daily 2, 3

Important Caveats

While bisoprolol is longer-acting, both drugs are effective beta-blockers with proven mortality benefits in heart failure (bisoprolol in CIBIS-II 10, 11, 12; propranolol post-MI). The choice between them should also consider:

  • Cardioselectivity: Bisoprolol is beta-1 selective 1, 8, making it preferable in patients with bronchospastic disease
  • Lipophilicity: Propranolol's high lipid solubility may cause more CNS side effects (vivid dreams, fatigue) 4
  • Drug interactions: Propranolol has more potential for hepatic enzyme interactions 5, 4

For conditions requiring sustained 24-hour beta-blockade (hypertension, heart failure, angina), bisoprolol's pharmacokinetic profile with once-daily dosing is superior to immediate-release propranolol. Extended-release propranolol formulations narrow this gap but still have a shorter half-life than bisoprolol 6.

References

Research

Bisoprolol: a new beta-adrenoceptor blocking drug.

European heart journal, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.